| |
Atrial |
No atrial |
p value |
| Dilatation |
dilatation |
| Patients, N |
2,268 |
5,409 |
|
| Clinical characteristics |
| Age (years) |
68±16 |
65±17 |
<0.001 |
| Gender (males) |
1,012 (45%) |
2,485 (46%) |
0.289 |
| Cancer |
390 (17%) |
940 (17%) |
0.847 |
| Chronic heart failure |
368 (16%) |
418 (7.7%) |
<0.001 |
| Chronic lung disease |
382 (17%) |
684 (13%) |
<0.001 |
| Physical examination |
| Heart rate (bpm) |
97±21 |
92±20 |
<0.001 |
| Systolic blood pressure levels (mm Hg) |
127±23 |
131±23 |
<0.001 |
| Electrocardiogram |
| Atrial fibrillation |
305 (13%) |
352 (6.5%) |
<0.001 |
| Right bundle branch block |
608 (29%) |
749 (15%) |
<0.001 |
| S1Q3T3pattern |
624 (30%) |
797 (16%) |
<0.001 |
| Laboratory tests |
| Creatinine levels >1.2 mg/dL |
507 (22%) |
845 (16%) |
<0.001 |
| PO2 levels (mm Hg) (N=5,215) |
62±19 |
68±22 |
<0.001 |
| Sat O2 levels (%) (N=5,438) |
89±7 |
92±6 |
<0.001 |
| Echocardiogram |
| RA diameter (cm) (N=207) |
4.3±1.5 |
3.3±1.6 |
<0.001 |
| Visualization of thrombus |
105 (4.6%) |
67 (1.2%) |
<0.001 |
| RV hypokinesis |
1,185 (52%) |
562 (10%) |
<0.001 |
| PAP levels (mm Hg) (N=4,649) |
55±18 |
39±15 |
<0.001 |
| RV diameter (cm) (N=1,314) |
3.9±1.2 |
3.0±0.7 |
<0.001 |
| TAPSE (cm) (N=1,590) |
1.8±0.8 |
2.1±0.9 |
<0.001 |
|
